This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Should Vanguard Small-Cap ETF (VB) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VB
Mastercard Ties Up to Strengthen Digital Payments Across EEMEA
by Zacks Equity Research
MA partners with MTN, Emirates NBD, Sadad and Checkout.com to leverage its technology and promote the widespread uptake of digital payments across EEMEA.
5 Must-Buy Momentum Stocks for March After a Disappointing February
by Nalak Das
Top five momentum picks for March are: AFRM, APP, SFM, HOOD, CVNA.
Astera Labs (ALAB) and AppLovin (APP) Are Aggressive Growth Stocks
by Brian Bolan
Two More Stocks for your Aggressive Growth Stock Radar Screen.
AppLovin (APP) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
AppLovin (APP) could produce exceptional returns because of its solid growth attributes.
Is AppLovin (APP) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in AppLovin (APP). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Investors Heavily Search AppLovin Corporation (APP): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to AppLovin (APP). This makes it worthwhile to examine what the stock has in store.
Can AppLovin (APP) Stock Bounce Back Amid Recent Market Volatility?
by Shaun Pruitt
Prior to the broader market selloff over the last week, AppLovin (APP) had been one of the hottest stocks this year.
Zacks.com featured highlights Brinker, AppLovin and Phibro Animal Health
by Zacks Equity Research
Brinker, AppLovin and Phibro Animal Health have been highlighted in this Screen of The Week article.
3 Strong Buy Stocks for the Momentum Investor
by Tirthankar Chakraborty
Brinker International, AppLovin and Phibro Animal Health have been selected as the momentum picks for the day using the Driehaus strategy.
Wall Street Analysts Believe AppLovin (APP) Could Rally 32.97%: Here's is How to Trade
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 33% in AppLovin (APP). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
The Zacks Analyst Blog Highlights Affirm, Visa, Palantir, AppLovin and Cintas
by Zacks Equity Research
Affirm, Visa, Palantir, AppLovin and Cintas are included in this Analyst Blog.
Zacks Industry Outlook Highlights AppLovin, Byrna Technologies and LiveRamp
by Zacks Equity Research
AppLovin, Byrna Technologies and LiveRamp have been highlighted in this Industry Outlook article.
3 Stocks to Buy From the Booming Technology Services Industry
by Zacks Equity Research
Robust growth since the pandemic, driven by the swift adoption of remote work and other technological advancements, should drive the Zacks Technology Services industry. APP, RAMP and BYRN are well-positioned to capitalize on the rising demand.
Buy 5 Business Services Stocks as U.S. CEO Confidence Hits 3-Year High
by Nalak Das
Five business services stocks have strong growth potential for 2025 and 2026. These are: AFRM, V, PLTR, APP, CTAS.
Are Business Services Stocks Lagging AppLovin (APP) This Year?
by Zacks Equity Research
Here is how AppLovin (APP) and Palantir Technologies Inc. (PLTR) have performed compared to their sector so far this year.
Best Momentum Stocks to Buy for February 18th
by Zacks Equity Research
ROKU, APP and FINW made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 31, 2024.
Earnings Estimates Rising for AppLovin (APP): Will It Gain?
by Zacks Equity Research
AppLovin (APP) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
What Makes AppLovin (APP) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does AppLovin (APP) have what it takes to be a top stock pick for momentum investors? Let's find out.
Here is What to Know Beyond Why AppLovin Corporation (APP) is a Trending Stock
by Zacks Equity Research
AppLovin (APP) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Is First Trust Multi Cap Growth AlphaDEX ETF (FAD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FAD
AppLovin Corporation (APP) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
AppLovin (APP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Gaming ETF (ESPO) Hits New 52-Week High
by Sanghamitra Saha
The gaming ETF ESPO hit a new 52-week high lately. Can it soar higher?
AppLovin Stock Rises 34% in 3 Months: Buy or Wait for a Pullback?
by Shuvra Shankar Dey
In light of the ongoing rise in APP shares, we assess the stock's current position to determine the best strategy for the future.
AppLovin, Dutch Bros Surge More Than 30% Following Upbeat Q4 Results
by Bryan Hayes
As good as analysts are at predicting corporate earnings, it seems that a few companies are making that job increasingly difficult.